Malavika Deodhar, BPharm, PhD is a clinical research scientist at TRHC. Dr. Deodhar completed her BPharm at Bombay College of Pharmacy in India and her PhD in pharmacology from Creighton University in Omaha, Nebraska. She received multiple travel awards during her PhD to attend conferences, including the American Airlines Global Scholars Award. Dr Deodhar has experience designing preclinical experiments, especially for epilepsy animal models. In addition, she has worked with consulting companies on clinical development strategy for abbreviated NDAs and 505(b)(2) FDA applications for pharma companies. Dr Deodhar is currently working on projects involving pharmacogenomics implementation and others to improve TRHCs clinical decision support software.